Global HPV Testing Market 2016-2020; New Report Launched

DrugPipeline.net has announced the addition of “Global HPV Testing Market 2016-2020” research report to their website DrugPipeline.net


Bangalore, Karnataka -- (SBWIRE) -- 01/26/2017 -- According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Report forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The market is divided into the following segments based on geography:
- Americas

Technavio's report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- BD
- Roche Diagnostics
- Qiagen

Other prominent vendors
- Arbor Vita
- Breakspear Medical
- Cepheid
- DAAN Gene
- DiaCarta
- Delphi Bioscience
- Fujirebio Diagnostics
- Genera Biosystems
- IncellDx
- OralDNA Labs
- Seegene
- SoloPap
- Trovagene

Market driver
- Early detection of cervical cancer to prevent the growing prevalence
- For a full, detailed list, view our report

Market challenge
- Pap test: Alternative diagnostic tests for cervical cancer screening
- For a full, detailed list, view our report

Market trend
- Expansion of companies in key markets
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 80 pages "Global HPV Testing Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by product, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-hpv-testing-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.